open access

Vol 25, No 5 (2018)
EDITORIALS
Published online: 2018-10-30
Get Citation

Routine angiographic follow-up for left main percutaneous coronary intervention: Back to the old times?

Marcelo Sanmartin, Ramesh Daggubati
DOI: 10.5603/CJ.2018.0127
·
Pubmed: 30394513
·
Cardiol J 2018;25(5):571-573.

open access

Vol 25, No 5 (2018)
EDITORIALS
Published online: 2018-10-30

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Routine angiographic follow-up for left main percutaneous coronary intervention: Back to the old times?

Journal

Cardiology Journal

Issue

Vol 25, No 5 (2018)

Pages

571-573

Published online

2018-10-30

DOI

10.5603/CJ.2018.0127

Pubmed

30394513

Bibliographic record

Cardiol J 2018;25(5):571-573.

Authors

Marcelo Sanmartin
Ramesh Daggubati

References (12)
  1. Jukema JW, Verschuren JJW, Ahmed TAN, et al. Restenosis after PCI. Part 1: pathophysiology and risk factors. Nat Rev Cardiol. 2011; 9(1): 53–62.
  2. ten Berg JM, Kelder JC, Suttorp MJ, et al. Influence of planned six-month follow-up angiography on late outcome after percutaneous coronary intervention: a randomized study. J Am Coll Cardiol. 2001; 38(4): 1061–1069.
  3. Uchida T, Popma J, Stone GW, et al. The clinical impact of routine angiographic follow-up in randomized trials of drug-eluting stents: a critical assessment of "oculostenotic" reintervention in patients with intermediate lesions. JACC Cardiovasc Interv. 2010; 3(4): 403–11.
  4. Aurigemma C, Burzotta F, Porto I, et al. Clinical impact of routine angiographic follow-up after percutaneous coronary interventions on unprotected left main. Cardiol J. 2018; 25(5): xx–xx.
  5. Biondi-Zoccai GGL, Giraudi E, Moretti C, et al. Impact of routine angiographic follow-up after percutaneous coronary drug-eluting stenting for unprotected left main disease: the Turin Registry. Clin Res Cardiol. 2010; 99(4): 235–242.
  6. D'Ascenzo F, Iannaccone M, Pavani M, et al. Planned angiographic control versus clinical follow-up for patients with unprotected left main stem stenosis treated with second generation drug-eluting stents: A propensity score with matching analysis from the FAILS (failure in left main with second generation stents-Cardiogroup III Study). Catheter Cardiovasc Interv. 2017 [Epub ahead of print].
  7. Morice MC, Serruys PW, Kappetein AP, et al. Five-Year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial. Circulation. 2014; 129(23): 2388–2394.
  8. Stone G, Sabik J, Serruys P, et al. Everolimus-eluting stents or bypass surgery for left main coronary artery disease. N Engl J Med. 2016; 375(23): 2223–2235.
  9. Shiomi H, Morimoto T, Kitaguchi S, et al. The ReACT Trial. JACC: Cardiovascular Interventions. 2017; 10(2): 109–117.
  10. Andreou I, Stone PH. In-stent atherosclerosis at a crossroads: neoatherosclerosis … or paleoatherosclerosis? Circulation. 2016; 134(19): 1413–1415.
  11. Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2018 [Epub ahead of print].
  12. Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2011; 124(23): e574–e651.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl